Delivery Order SPE2DB24D2215-SPE2DB25FGRXQ
Award Date
10/16/24
Potential Completion Date
10/17/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $9,215.11 for the supply of 4,564,158,437 units of Colchicine 0.6 mg capsules. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 4, 2024. The contract is a firm fixed-price type, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMDNV, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,445.09 firm fixed-price delivery order is for the supply of 4566640101 - Colchicine 0.6 mg capsules in 100-count bottles. The contract has an ultimate completion date of December 9, 2024 and was awarded on December 6, 2024. AmerisourceBergen holds a significant $999,999,999...
This contract award is an order for 4,567,072,377 units of Colchicine 0.6 mg capsules, placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp. The $10,997.03 firm fixed-price delivery order has a completion date of January 29, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,004.43, is for the supply of 4561987072 Colchicine 0.6 mg Tablets, packaged in 100s. The contract is a Delivery Order with a Firm Fixed Price pricing type, and an ultimate completion date of August 30, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of colchicine 0.6 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,512.07 and a completion date of April 4, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,145.44 firm fixed-price delivery order contract is for the supply of 4568112339 - CHEMET 100 MG CAPSULE 100S, a medication. The contract is not set aside and has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $9,743.99 for the supply of 60 capsules of the medication Lubiprostone 24 MCG. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 7, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical...
This federal contract award, valued at $555,186.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed-price pricing type and an ultimate completion date of March 12, 2024. The award is not set aside for any specific business type, indicating open competition. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc.,...
The U.S. government awarded a Firm Fixed Price delivery order contract valued at $29,019.08 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of COLUMVI 10 MG/10 ML VIAL 10ML. This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
This federal contract award, valued at $762,206.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of January 29, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...